Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

Table 3

Baseline medications of patients in the clopidogrel and ticagrelor groups, n (%).

	Clopidogrel	Ticagrelor	value
	(n = 223)	(n = 214)
Statins	219 (98.2%)	210 (98.1%)	1
Beta-blockers	154 (69.1%)	132 (61.7%)	0.109
Diuretics	29 (13%)	22 (10.3%)	0.456
Calcium channel blockers	47 (21.1%)	41 (19.2%)	0.635
Angiotensin-converting enzyme inhibitors	32 (14.3%)	13 (6.1%)	0.005
Angiotensin II receptor blockers	86 (38.6%)	93 (43.5%)	0.331
Nitrates	75 (33.6%)	106 (49.5%)	0.001
Proton pump inhibitors	78 (35%)	85 (39.7%)	0.323